Feragyl Biocare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.10 M
- Revenue Growth 12.35%
- Profit Growth 56.97%
- Ebitda 301.00%
- Net Worth 104.23%
- Total Assets 18.51%
About Feragyl Biocare
Feragyl Biocare Private Limited (FBPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 July 2017 (Seven years and six months 11 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹3.10 M.
Ravindra Yadav and Sunil Kumar serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290UP2017PTC095530
-
Company No.
095530
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jul 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Feragyl Biocare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Yadav
|
Director | 31-Jul-2017 | Current |
|
Sunil Kumar
|
Director | 31-Jul-2017 | Current |
Financial Performance of Feragyl Biocare.
Feragyl Biocare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 12.35% increase. The company also saw a substantial improvement in profitability, with a 56.97% increase in profit. The company's net worth Soared by an impressive increase of 104.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Feragyl Biocare?
In 2019, Feragyl Biocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.10 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jun 2023 | Hdfc Bank Limited | ₹3.10 M | Open |
How Many Employees Work at Feragyl Biocare?
Feragyl Biocare has a workforce of 10 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Feragyl Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Feragyl Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.